AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19286598 — intervention group
Group type: EXPERIMENTAL
Intervention: National Institute of Neurological Diseases and Stroke intravenous recombinant tissue plasminogen activator trial
Number of subjects: 0
Study 19286598 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke‐Acute Ischemic NXY Treatment and Abciximab Emergent Stroke Treatment Trial
Number of subjects: 0
Study 19286598 — intervention group
Group type: COMPARATOR
Intervention: Pooled control arms from randomized controlled trials
Number of subjects: 0
Study 17468087 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc + Iron + Vitamin A (Zn+Fe+vit.A)
Number of subjects: 800
Study 17468087 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc + Iron (Zn+Fe)
Number of subjects: 800
Study 17468087 — intervention group
Group type: COMPARATOR
Intervention: Zinc alone (Zn)
Number of subjects: 800
Study 17468087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 16181237 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid infusion
Number of subjects: 6
Study 16181237 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study 11879254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg (intravenous)
Number of subjects: 78
Study 11879254 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 100 mg (oral) in fed state
Number of subjects: 78
Study 11879254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg (oral) in fasted state
Number of subjects: 78
Study 11879254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil doses of 25, 50, 100, and 200 mg (oral)
Number of subjects: 78
Study 11879254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (various doses)
Number of subjects: 78
Study 10073874 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepress program for self-measurement of blood pressure
Number of subjects: 30
Study 7721431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid/heparin
Number of subjects: 19
Study 7721431 — intervention group
Group type: COMPARATOR
Intervention: saline/heparin
Number of subjects: 19
Study 7721431 — intervention group
Group type: COMPARATOR
Intervention: dextrose/heparin
Number of subjects: 19
Study 1645503 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral therapy with azithromycin
Number of subjects: 0
Study 1645503 — intervention group
Group type: COMPARATOR
Intervention: Standard 7-day twice-daily course of doxycycline
Number of subjects: 0
Study 6939008 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 6
Study 31034640 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 min/wk aerobic exercise (HIGH dose group)
Number of subjects: 400
Study 31034640 — intervention group
Group type: COMPARATOR
Intervention: 150 min/wk aerobic exercise (MODERATE dose group)
Number of subjects: 400
Study 31034640 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact exercises (exploratory analysis)
Number of subjects: 400
Study 29514699 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-reframing (RR) digital tool and in-person workshop
Number of subjects: 501
Study 29514699 — intervention group
Group type: COMPARATOR
Intervention: Position Statement on Active Outdoor Play (Control)
Number of subjects: 501
Study 26930244 — intervention group
Group type: EXPERIMENTAL
Intervention: Medulla powder (15 g/day)
Number of subjects: 90
Study 26930244 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole fruit powder (15 g/day)
Number of subjects: 90
Study 26930244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 24835379 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophageal flap valvuloplasty and wrapping suturing technique
Number of subjects: 394
Study 24835379 — intervention group
Group type: COMPARATOR
Intervention: Traditional techniques (Control)
Number of subjects: 394
Study 22702540 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis stimulating agents (ESAs)
Number of subjects: 302
Study 22702540 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor response to ESAs
Number of subjects: 302
Study 22702540 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and co-morbidities
Number of subjects: 302
Study 19915503 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + PRO
Number of subjects: 8
Study 19915503 — intervention group
Group type: COMPARATOR
Intervention: CHO
Number of subjects: 8
Study 17634728 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing 550 microg F/g, pH 5.5 (experimental)
Number of subjects: 6
Study 17634728 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice containing 1, 100 microg F/g, pH 7.0 (positive control)
Number of subjects: 6
Study 17634728 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoridated dentifrice (negative control)
Number of subjects: 6
Study 15070956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet (1.3 g, 57 mmol)
Number of subjects: 36
Study 15070956 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium diet (4 g, 172 mmol)
Number of subjects: 36
Study 11778680 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization bootstrap
Number of subjects: 0
Study 11778680 — intervention group
Group type: COMPARATOR
Intervention: Established approach (randomization or permutation tests)
Number of subjects: 0
Study 9893098 — intervention group
Group type: EXPERIMENTAL
Intervention: Cafestol (1, 2, or 3 cups of French-press coffee)
Number of subjects: 9
Study 9893098 — intervention group
Group type: EXPERIMENTAL
Intervention: Kahweol (1, 2, or 3 cups of French-press coffee)
Number of subjects: 9
Study 9893098 — intervention group
Group type: EXPERIMENTAL
Intervention: Cafestol
Number of subjects: 9
Study 9893098 — intervention group
Group type: EXPERIMENTAL
Intervention: Kahweol
Number of subjects: 9
Study 8064943 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate (5 mg base kg‐1)
Number of subjects: 2000
Study 8064943 — intervention group
Group type: COMPARATOR
Intervention: Placebo (multivitamin tablet)
Number of subjects: 2000
Study 3056948 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous reduction and external fixation
Number of subjects: 31
Study 3056948 — intervention group
Group type: COMPARATOR
Intervention: Closed manipulation
Number of subjects: 31
Study 1200338 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular chlorprothixene (1 mg/kg)
Number of subjects: 200
Study 1200338 — intervention group
Group type: COMPARATOR
Intervention: Oral chlorprothixene (4% solution, 1.5-2 mg/kg)
Number of subjects: 200
Study 1200338 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular 1-hyoscyamine (0.005-0.01 mg/kg)
Number of subjects: 200
Study 31831845 — intervention group
Group type: EXPERIMENTAL
Intervention: Haploidentical donor (HID) transplantation
Number of subjects: 189
Study 31831845 — intervention group
Group type: COMPARATOR
Intervention: HLA-matched sibling donor (MSD) transplantation
Number of subjects: 189
Study 30905725 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 D more hyperopic refractive error
Number of subjects: 33526
Study 30905725 — intervention group
Group type: COMPARATOR
Intervention: Mendelian randomization analysis
Number of subjects: 33526
Study 28637654 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument-based vision screening
Number of subjects: 12
Study 26001837 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac output-guided haemodynamic therapy
Number of subjects: 723
Study 26001837 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 723
Study 21983702 — intervention group
Group type: EXPERIMENTAL
Intervention: Spacer plate with 6 weeks of feather-touch weight bearing
Number of subjects: 30
Study 21983702 — intervention group
Group type: COMPARATOR
Intervention: Plate fixator with 2 weeks of feather-touch weight bearing
Number of subjects: 30
Study 20882294 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate fatigue sensation (Borg's CR‐10 3) during static contractions
Number of subjects: 11
Study 20882294 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong fatigue sensation (Borg's CR‐10 5) during static contractions
Number of subjects: 11
Study 20882294 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% maximum pulling force (MVC) during static contractions
Number of subjects: 11
Study 20882294 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% maximum pulling force (MVC) during static contractions
Number of subjects: 11
Study 20882294 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest condition with stretch exercise
Number of subjects: 11
Study 20882294 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest condition without stretch exercise
Number of subjects: 11
Study 18303227 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with low-dosage mitomycin C (DSMMC)
Number of subjects: 40
Study 18303227 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with low-dosage mitomycin C (TPMMC)
Number of subjects: 40
Study 16938002 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-session educational intervention
Number of subjects: 165
Study 12563691 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of x-ray technologists in fluoroscopically assisted semiflexed knee examination and quality control criteria (QCC) for film acceptance.
Number of subjects: 199
Study 12563691 — intervention group
Group type: EXPERIMENTAL
Intervention: NA technologists' JSW measurement
Number of subjects: 199
Study 12563691 — intervention group
Group type: EXPERIMENTAL
Intervention: EU technologists' JSW measurement
Number of subjects: 199
Study 12563691 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall technologists' reproducibility
Number of subjects: 199
Study 12563691 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproducibility in joint repositioning
Number of subjects: 199
Study 12563691 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-continent precision of JSW measurements
Number of subjects: 199
Study 10661690 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (75 ml)
Number of subjects: 12
Study 10661690 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 12
Study 10661690 — intervention group
Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 12
Study 9403805 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH injection (0.2 mg protirelin, iv)
Number of subjects: 10
Study 9403805 — intervention group
Group type: COMPARATOR
Intervention: Atropine (1 mg, iv)
Number of subjects: 10
Study 8170764 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced walking at controlled moderate intensity for 30 min at 11:50 a.m.
Number of subjects: 120
Study 8170764 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced walking at controlled moderate intensity for 40 min at 11:50 a.m.
Number of subjects: 120
Study 8170764 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced walking at controlled moderate intensity for 30 min at 2:20 p.m.
Number of subjects: 120
Study 8170764 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced walking at controlled moderate intensity for 40 min at 2:20 p.m.
Number of subjects: 120
Study 8170764 — intervention group
Group type: COMPARATOR
Intervention: Paced walking at controlled moderate intensity for 20 min at any time of the day.
Number of subjects: 120
Study 3535446 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 33
Study 3535446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 30009636 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality training promoting exercise
Number of subjects: 64
Study 30009636 — intervention group
Group type: COMPARATOR
Intervention: Routine care (advice on physical activities)
Number of subjects: 64
Study 30186631 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged hemodialysis (PHD) sessions lasting 10 hours
Number of subjects: 194
Study 30186631 — intervention group
Group type: COMPARATOR
Intervention: Prolonged hemodialysis (PHD) sessions lasting 6 hours
Number of subjects: 194
Study 30186631 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged hemodialysis (PHD) sessions (both 6h and 10h)
Number of subjects: 194
Study 27768517 — intervention group
Group type: EXPERIMENTAL
Intervention: No fluid intake (NF)
Number of subjects: 8
Study 27768517 — intervention group
Group type: COMPARATOR
Intervention: Water intake (WATER)
Number of subjects: 8
Study 26242177 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of rocuronium 0.6 mg/kg per hour
Number of subjects: 66
Study 26242177 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of NaCl 0.9 % 0.06 ml/kg per hour
Number of subjects: 66
Study 23954097 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1,000 mg as elemental calcium) with vitamin D‐3 (400 IU) daily
Number of subjects: 1911
Study 23954097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1911
Study 20948291 — intervention group
Group type: EXPERIMENTAL
Intervention: Muromonab CD3 (monoclonal antibody targeting CD3)
Number of subjects: 0
Study 20948291 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel monoclonal antibodies targeting co‐stimulatory signals, cell surface receptors, and novel protein constructs
Number of subjects: 0
Study 18853593 — intervention group
Group type: EXPERIMENTAL
Intervention: Miller blade with paraglossal approach
Number of subjects: 161
Study 18853593 — intervention group
Group type: COMPARATOR
Intervention: Macintosh blade using standard approach
Number of subjects: 161
Study 16844630 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonanno catheter
Number of subjects: 38
Study 16844630 — intervention group
Group type: COMPARATOR
Intervention: Tube thoracostomy
Number of subjects: 38
Study 12727577 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive lipid-lowering strategy involving up to 80 mg/d of atorvastatin with a target LDL cholesterol level <77 mg/dL
Number of subjects: 60
Study 12727577 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive lipid-lowering strategy
Number of subjects: 60
Study 12727577 — intervention group
Group type: COMPARATOR
Intervention: Usual therapy of lipids with LDL cholesterol target level <116 mg/dL
Number of subjects: 60
Study 11253439 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased age
Number of subjects: 2324
Study 11253439 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 2324
Study 11253439 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater sun sensitivity
Number of subjects: 2324
Study 9404128 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 60
Study 9404128 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anesthesia (nitrous oxide-oxygen-isoflurane/sevoflurane)
Number of subjects: 60
Study 8222384 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg SIN-1 administered via intracoronary route
Number of subjects: 21
Study 8222384 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg SIN-1 administered via intravenous route
Number of subjects: 21
Study 8222384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3899346 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil (CLR) plus Prednisone (PDN)
Number of subjects: 96
Study 3899346 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (COP)
Number of subjects: 96
Study 3899346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with previous treatment
Number of subjects: 96
Study 3899346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with no previous treatment
Number of subjects: 96
Study 3899346 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Remission (CR) or good Partial Remission (PR)
Number of subjects: 96
Study 31564118 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta made with 60% semolina flour and 40% sprouted chickpea flour (SCF40)
Number of subjects: 22
Study 31564118 — intervention group
Group type: COMPARATOR
Intervention: Pasta made with 100% semolina flour (SEM100)
Number of subjects: 22
Study 29444768 — intervention group
Group type: EXPERIMENTAL
Intervention: Just-in-time information and feedback (JITIF) intervention
Number of subjects: 1048
Study 27821144 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic surgery
Number of subjects: 36
Study 27821144 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgery
Number of subjects: 36
Study 24851997 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic platelet transfusion to maintain platelet counts at or above 50 × 10(9)/l
Number of subjects: 660
Study 24851997 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic platelet transfusion to maintain platelet counts at or above 25 × 10(9)/l
Number of subjects: 660
Study 22871584 — intervention group
Group type: EXPERIMENTAL
Intervention: Straw provided for forage and bedding
Number of subjects: 30
Study 22871584 — intervention group
Group type: COMPARATOR
Intervention: No straw provided
Number of subjects: 30
Study 20177844 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive internet smoking cessation program
Number of subjects: 2153
Study 18780884 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning-based sensorimotor training (LBSMT) - Group I (1x/week, 1.5 hours/visit)
Number of subjects: 45
Study 18780884 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning-based sensorimotor training (LBSMT) - Group II (3x/week, 0.75 hours/visit)
Number of subjects: 45
Study 18780884 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning-based sensorimotor training (LBSMT) - Group III (4x/week, 3 hours/visit)
Number of subjects: 45
Study 11174383 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interferon alfa‐2a and extracorporeal photochemotherapy
Number of subjects: 14
Study 9390111 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 25 mg
Number of subjects: 48
Study 9390111 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 100 mg
Number of subjects: 48
Study 9390111 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 1 mg
Number of subjects: 48
Study 9390111 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 5 mg
Number of subjects: 48
Study 9390111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 7962372 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical vaporization of the ovarian capsule (22 women)
Number of subjects: 44
Study 7962372 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple perforation of the ovarian capsule with subcapsular destruction of the ovarian stroma (22 women)
Number of subjects: 44
Study 7962372 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall conception rate after laparoscopic argon laser treatment
Number of subjects: 44
Study 7962372 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate therapy post-operatively
Number of subjects: 44
Study 7962372 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall conception rate
Number of subjects: 44
Study 3308477 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 62
Study 3308477 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC)
Number of subjects: 62
Study 3308477 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (DMP)
Number of subjects: 62
Study 28642082 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000IU vitamin D supplements
Number of subjects: 68
Study 26327975 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal contraceptive counselling (home visits and telephone consultations)
Number of subjects: 1385
Study 26327975 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal care (control group)
Number of subjects: 1385
Study 26327975 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal contraceptive counselling (intervention group)
Number of subjects: 1385
Study 24246825 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneas from donors aged 12 to 65 years
Number of subjects: 1090
Study 24246825 — intervention group
Group type: COMPARATOR
Intervention: Corneas from donors aged 66 to 75 years
Number of subjects: 1090
Study 24246825 — intervention group
Group type: EXPERIMENTAL
Intervention: Donors aged 34 to 71 years
Number of subjects: 1090
Study 24246825 — intervention group
Group type: EXPERIMENTAL
Intervention: Donors aged 12 to 33 years
Number of subjects: 1090
Study 24246825 — intervention group
Group type: EXPERIMENTAL
Intervention: Donors aged 72 to 75 years
Number of subjects: 1090
Study 21143245 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater subjective alcohol intoxication
Number of subjects: 1867
Study 21143245 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighter drinking
Number of subjects: 1867
Study 21143245 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of alcohol problems
Number of subjects: 1867
Study 21143245 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher estimated blood alcohol concentrations (eBACs)
Number of subjects: 1867
Study 21143245 — intervention group
Group type: EXPERIMENTAL
Intervention: Students with greater subjective intoxication
Number of subjects: 1867
Study 18258620 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFAs
Number of subjects: 20
Study 18258620 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO/N3
Number of subjects: 20
Study 18258620 — intervention group
Group type: COMPARATOR
Intervention: SFAs
Number of subjects: 20
Study 18258620 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty meals (SFA, MUFA, CHO/N3)
Number of subjects: 20
Study 17033039 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 60 mg/m2
Number of subjects: 527
Study 17033039 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2
Number of subjects: 527
Study 17033039 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m2
Number of subjects: 527
Study 17033039 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (all doses)
Number of subjects: 527
Study 14585088 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program (8 weeks of supervised endurance exercise, 75% VO(2peak), 45 min twice a week, with intermittent exercise once a week)
Number of subjects: 16
Study 14585088 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program
Number of subjects: 16
Study 14585088 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 10922194 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir, 800 mg/d
Number of subjects: 703
Study 10922194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 703